1. Home
  2. SNGX vs OBLG Comparison

SNGX vs OBLG Comparison

Compare SNGX & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • OBLG
  • Stock Information
  • Founded
  • SNGX 1987
  • OBLG 2000
  • Country
  • SNGX United States
  • OBLG United States
  • Employees
  • SNGX N/A
  • OBLG N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • SNGX Health Care
  • OBLG Technology
  • Exchange
  • SNGX Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • SNGX 6.5M
  • OBLG 5.5M
  • IPO Year
  • SNGX 1987
  • OBLG N/A
  • Fundamental
  • Price
  • SNGX $1.28
  • OBLG $4.89
  • Analyst Decision
  • SNGX
  • OBLG
  • Analyst Count
  • SNGX 0
  • OBLG 0
  • Target Price
  • SNGX N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • SNGX 2.7M
  • OBLG 102.5K
  • Earning Date
  • SNGX 08-08-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • SNGX N/A
  • OBLG N/A
  • EPS Growth
  • SNGX N/A
  • OBLG N/A
  • EPS
  • SNGX N/A
  • OBLG N/A
  • Revenue
  • SNGX $2,342.00
  • OBLG $2,374,000.00
  • Revenue This Year
  • SNGX N/A
  • OBLG N/A
  • Revenue Next Year
  • SNGX N/A
  • OBLG N/A
  • P/E Ratio
  • SNGX N/A
  • OBLG N/A
  • Revenue Growth
  • SNGX N/A
  • OBLG N/A
  • 52 Week Low
  • SNGX $1.09
  • OBLG $1.91
  • 52 Week High
  • SNGX $8.55
  • OBLG $7.97
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.55
  • OBLG 63.31
  • Support Level
  • SNGX $1.09
  • OBLG $4.40
  • Resistance Level
  • SNGX $1.88
  • OBLG $4.97
  • Average True Range (ATR)
  • SNGX 0.14
  • OBLG 0.50
  • MACD
  • SNGX -0.01
  • OBLG 0.10
  • Stochastic Oscillator
  • SNGX 22.78
  • OBLG 90.26

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: